In this study, we found that DMD patient-specific iPSC-derived CMs (iPSC-CMs) exhibited dystrophin deficiency, as well as increased levels of cytosolic Ca2+, mitochondria damage, CASP3 activation and cell apoptosis. The gene discussed is CASP3; the disease is Duchenne muscular dystrophy.